UBS AM’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4M | Buy |
704,357
+99,411
| +16% | +$4.29M | 0.01% | 885 |
|
|
2025
Q1 | $20.9M | Sell |
604,946
-4,642
| -0.8% | -$160K | 0.01% | 950 |
|
|
2024
Q4 | $16.7M | Sell |
609,588
-50,677
| -8% | -$1.39M | ﹤0.01% | 1031 |
|
|
2024
Q3 | $16.8M | Sell |
660,265
-45,862
| -6% | -$1.17M | ﹤0.01% | 1015 |
|
|
2024
Q2 | $17.9M | Buy |
706,127
+64,232
| +10% | +$1.63M | 0.01% | 900 |
|
|
2024
Q1 | $19.8M | Sell |
641,895
-18,323
| -3% | -$567K | 0.01% | 795 |
|
|
2023
Q4 | $26.7M | Sell |
660,218
-35,415
| -5% | -$1.43M | 0.01% | 720 |
|
|
2023
Q3 | $18.3M | Sell |
695,633
-8,853
| -1% | -$233K | 0.01% | 775 |
|
|
2023
Q2 | $11.7M | Hold |
704,486
| – | – | 0.01% | 910 |
|
|
2023
Q1 | $11.7M | Buy |
704,486
+600,521
| +578% | +$9.96M | 0.01% | 910 |
|
|
2022
Q4 | $792K | Sell |
103,965
-3,873
| -4% | -$29.5K | ﹤0.01% | 1968 |
|
|
2022
Q3 | $1.07M | Buy |
107,838
+23,150
| +27% | +$230K | ﹤0.01% | 1922 |
|
|
2022
Q2 | $769K | Buy |
84,688
+19,229
| +29% | +$175K | ﹤0.01% | 2100 |
|
|
2022
Q1 | $664K | Buy |
65,459
+498
| +0.8% | +$5.06K | ﹤0.01% | 2351 |
|
|
2021
Q4 | $1.08M | Sell |
64,961
-5,735
| -8% | -$95.7K | ﹤0.01% | 2173 |
|
|
2021
Q3 | $3.31M | Buy |
70,696
+1,513
| +2% | +$70.9K | ﹤0.01% | 1569 |
|
|
2021
Q2 | $4.22M | Buy |
69,183
+29,742
| +75% | +$1.81M | ﹤0.01% | 1456 |
|
|
2021
Q1 | $2.43M | Sell |
39,441
-125,961
| -76% | -$7.76M | ﹤0.01% | 1677 |
|
|
2020
Q4 | $11.8M | Sell |
165,402
-8,993
| -5% | -$639K | 0.01% | 1002 |
|
|
2020
Q3 | $6.54M | Sell |
174,395
-2,556
| -1% | -$95.9K | ﹤0.01% | 1066 |
|
|
2020
Q2 | $5.77M | Buy |
176,951
+8,005
| +5% | +$261K | ﹤0.01% | 1063 |
|
|
2020
Q1 | $4.9M | Buy |
168,946
+92,212
| +120% | +$2.67M | ﹤0.01% | 1054 |
|
|
2019
Q4 | $2.69M | Sell |
76,734
-217
| -0.3% | -$7.61K | ﹤0.01% | 1468 |
|
|
2019
Q3 | $1.65M | Buy |
76,951
+1,951
| +3% | +$41.9K | ﹤0.01% | 1701 |
|
|
2019
Q2 | $2.02M | Buy |
+75,000
| New | +$2.02M | ﹤0.01% | 1586 |
|